EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $553,000 | -10.5% | 1,116,673 | -0.7% | 0.00% | – |
| Q4 2021 | $618,000 | -57.7% | 1,124,644 | 0.0% | 0.00% | – |
| Q3 2021 | $1,462,000 | -4.7% | 1,124,644 | +0.4% | 0.00% | – |
| Q2 2021 | $1,534,000 | -26.3% | 1,120,178 | -1.5% | 0.00% | – |
| Q1 2021 | $2,082,000 | -21.7% | 1,137,513 | +10.4% | 0.00% | – |
| Q4 2020 | $2,658,000 | -45.2% | 1,030,084 | -0.4% | 0.00% | – |
| Q3 2020 | $4,848,000 | +108.5% | 1,033,707 | +57.4% | 0.00% | – |
| Q2 2020 | $2,325,000 | +315.2% | 656,928 | +36.2% | 0.00% | – |
| Q1 2020 | $560,000 | -28.4% | 482,370 | 0.0% | 0.00% | – |
| Q4 2019 | $782,000 | +88.4% | 482,370 | 0.0% | 0.00% | – |
| Q3 2019 | $415,000 | +196.4% | 482,370 | +114.6% | 0.00% | – |
| Q2 2019 | $140,000 | -85.3% | 224,797 | -64.7% | 0.00% | – |
| Q1 2019 | $954,000 | -28.8% | 636,111 | +17.8% | 0.00% | – |
| Q4 2018 | $1,340,000 | -16.2% | 539,991 | +0.6% | 0.00% | – |
| Q3 2018 | $1,599,000 | +19.2% | 536,541 | 0.0% | 0.00% | – |
| Q2 2018 | $1,342,000 | +27.6% | 536,541 | +6.1% | 0.00% | – |
| Q1 2018 | $1,052,000 | -8.3% | 505,828 | -0.4% | 0.00% | – |
| Q4 2017 | $1,147,000 | -34.4% | 507,628 | -3.1% | 0.00% | – |
| Q3 2017 | $1,749,000 | +30.4% | 523,650 | 0.0% | 0.00% | – |
| Q2 2017 | $1,341,000 | -5.0% | 523,650 | +15.1% | 0.00% | – |
| Q1 2017 | $1,411,000 | +215.7% | 455,106 | +106.0% | 0.00% | – |
| Q4 2016 | $447,000 | -7.3% | 220,943 | +3.6% | 0.00% | – |
| Q3 2016 | $482,000 | +12.9% | 213,332 | +242.0% | 0.00% | – |
| Q2 2016 | $427,000 | +41.4% | 62,381 | +5.0% | 0.00% | – |
| Q1 2016 | $302,000 | +54.9% | 59,434 | +0.5% | 0.00% | – |
| Q4 2015 | $195,000 | -99.9% | 59,134 | -98.7% | 0.00% | -100.0% |
| Q3 2015 | $146,347,000 | +51612.7% | 4,452,877 | +8109.0% | 0.01% | – |
| Q2 2015 | $283,000 | -21.4% | 54,244 | +5.6% | 0.00% | – |
| Q1 2015 | $360,000 | +25.4% | 51,344 | +5.4% | 0.00% | – |
| Q4 2014 | $287,000 | +7.5% | 48,694 | 0.0% | 0.00% | – |
| Q3 2014 | $267,000 | -29.4% | 48,694 | +0.6% | 0.00% | – |
| Q2 2014 | $378,000 | -4.3% | 48,394 | +2.1% | 0.00% | – |
| Q1 2014 | $395,000 | +46.3% | 47,394 | +30.8% | 0.00% | – |
| Q4 2013 | $270,000 | – | 36,221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wambolt & Associates, LLC | 33,165 | $29,000 | 0.02% |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 400,000 | $344,000 | 0.00% |
| A.R.T. Advisors, LLC | 36,954 | $32,000 | 0.00% |
| NORTHERN TRUST CORP | 33,997 | $29,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 199,678 | $171,000 | 0.00% |
| CITIGROUP INC | 500 | $0 | 0.00% |
| MORGAN STANLEY | 1,450 | $1,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 36,700 | $32,000 | 0.00% |
| BlackRock Inc. | 54,940 | $47,000 | 0.00% |